Relapsed/Refractory CLL Treatment Options with Dr. Kerry Rogers

Dr. Kerry Rogers is a hematologist-oncologist dedicated to advancing the care and treatment of patients with chronic lymphocytic leukemia (CLL) and autoimmune cytopenias. Following her initial medical education at Chicago Medical School, she completed her residency in internal medicine at the University of Michigan. She then undertook fellowship at The Ohio State University in hematology and oncology, and after completion of her training, she was delighted to join the staff at the OSUCCC – James. In addition to clinical work, she spends time teaching medical students and resident physicians as an assistant professor in the Department of Hematology. As a member of the Leukemia Research Program at the OSUCCC – James, she conducts research in the Experimental Hematology Laboratory developing novel therapeutics for autoimmune cytopenias. Her research group has an interest in finding optimal strategies for the use of BTK inhibitors, including studying resistance, combination therapies and treatment discontinuation. She is currently the principal investigator on four open and two pending clinical trials in this area, including two investigator-sponsored trials and an NCI study. She has also written several articles for publication in medical journals such as Leukemia and Cancer Cell, and has prepared numerous abstracts and posters for presentations. What she loves most about The James is working with very passionate and committed team members to give patients the very best care. She feels that communication is a key aspect to providing the best medical care and enjoys spending time with her patients most of all.

Megan joined HealthTree as the Program Manager for CLL in 2022. She is the daughter of a blood cancer patient and has found a passion for helping support patients and caregivers to advance research for their cure and improve their quality of life.